These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 31786250

  • 1. A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
    Cubitt B, Ortiz-Riano E, Cheng BY, Kim YJ, Yeh CD, Chen CZ, Southall NOE, Zheng W, Martinez-Sobrido L, de la Torre JC.
    Antiviral Res; 2020 Jan; 173():104667. PubMed ID: 31786250
    [Abstract] [Full Text] [Related]

  • 2. The Pan-ErbB tyrosine kinase inhibitor afatinib inhibits multiple steps of the mammarenavirus life cycle.
    Mizuma K, Takashima A, Cubitt B, de la Torre JC, Iwasaki M.
    Virology; 2022 Nov; 576():83-95. PubMed ID: 36183499
    [Abstract] [Full Text] [Related]

  • 3. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
    Kim YJ, Cubitt B, Chen E, Hull MV, Chatterjee AK, Cai Y, Kuhn JH, de la Torre JC.
    Antiviral Res; 2019 Sep; 169():104558. PubMed ID: 31302150
    [Abstract] [Full Text] [Related]

  • 4. A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.
    Cai Y, Ye C, Cheng B, Nogales A, Iwasaki M, Yu S, Cooper K, Liu DX, Hart R, Adams R, Brady T, Postnikova EN, Kurtz J, St Claire M, Kuhn JH, de la Torre JC, Martínez-Sobrido L.
    mBio; 2020 Feb 25; 11(1):. PubMed ID: 32098811
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library.
    Lan X, Zhang Y, Jia X, Dong S, Liu Y, Zhang M, Guo J, Cao J, Guo Y, Xiao G, Wang W.
    Antiviral Res; 2022 Jan 25; 197():105230. PubMed ID: 34965446
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO, Cubitt B, Jacob NT, Janda KD, de la Torre JC.
    ACS Infect Dis; 2018 May 11; 4(5):815-824. PubMed ID: 29405696
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
    Wang P, Liu Y, Zhang G, Wang S, Guo J, Cao J, Jia X, Zhang L, Xiao G, Wang W.
    J Virol; 2018 Aug 15; 92(16):. PubMed ID: 29899092
    [Abstract] [Full Text] [Related]

  • 15. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE, Fénéant L, Szymańska-de Wijs KM, Kessler NP, Nelson EA, Shoemaker CJ, Schmaljohn CS, Polyak SJ, White JM.
    J Virol; 2019 Apr 15; 93(8):. PubMed ID: 30700611
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasmid-Based Lassa Virus Reverse Genetics.
    Martínez-Sobrido L, Ye C, de la Torre JC.
    Methods Mol Biol; 2024 Apr 15; 2733():115-131. PubMed ID: 38064030
    [Abstract] [Full Text] [Related]

  • 18. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.
    Welch SR, Guerrero LW, Chakrabarti AK, McMullan LK, Flint M, Bluemling GR, Painter GR, Nichol ST, Spiropoulou CF, Albariño CG.
    Antiviral Res; 2016 Dec 15; 136():9-18. PubMed ID: 27771389
    [Abstract] [Full Text] [Related]

  • 19. Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses.
    Rodrigo WW, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2011 Feb 15; 85(4):1684-95. PubMed ID: 21123370
    [Abstract] [Full Text] [Related]

  • 20. Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses.
    Iwasaki M, Minder P, Caì Y, Kuhn JH, Yates JR, Torbett BE, de la Torre JC.
    PLoS Pathog; 2018 Feb 15; 14(2):e1006892. PubMed ID: 29462184
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.